CXCL9 and cancer: QUE’s anti-inflammatory properties were also confirmed by the potent downregulation of pro-inflammatory chemokines, in particular the CXCR3 ligands CXCL9, CXCL10, and CXCL11, which are important players in chronic liver diseases [70], inflammation [71], and cancer [72].